Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Patent
1995-05-16
1997-08-05
Hulina, Amy
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
424434, 424455, 514946, 514947, A61K 3800
Patent
active
056539878
ABSTRACT:
A liquid pharmaceutical agent formulation suitable for oral or nasal delivery comprises a proteinic pharmaceutical agent, water and at least two absorption enhancing compounds. The absorption enhancing compounds are selected from sodium salicylate, sodium lauryl sulphate, disodium ethylenediaminetetraacetic acid (disodium EDTA), oleic acid, linoleic acid, monoolein, lecithin, lysolecithin, deoxycholate, sodium deoxycholate, chenodeoxycholate, taurodeoxycholate, glycochenodeoxycholate, polyoxyethylene X-lauryl ether wherein X is from 9 to 20, sodium tauro-24, 25-dihydrofusidate, polyoxyethylene ether, polyoxyethylene sorbitan esters, p-t-octylphenoxypolyoxyethylene, N-lauryl-.beta.-D-maltopyranoside, 1-dodecylazacycloheptane-2-azone and phospholipids, wherein the amount of each of the absorption enhancing compounds is present in a concentration of from 1 to 10 wt./wt. % of the total formulation. Preferably each of the absorption enhancing compounds is present in a concentration of from 1.5 to 3.5 wt./wt. % The formulation is particulary adapted to oral delivery of insulin.
REFERENCES:
patent: 4690952 (1987-09-01), Kagatani et al.
patent: 4900730 (1990-02-01), Miyauchi
patent: 5206219 (1993-04-01), Desai
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5447729 (1995-09-01), Belenduik et al.
patent: 5482706 (1996-01-01), Igari et al.
Chandarana Subash
Modi Pankaj
LandOfFree
Liquid formulations for proteinic pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid formulations for proteinic pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid formulations for proteinic pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072973